XML 19 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 19, 2019
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2018
REVENUES        
REVENUES $ 118,452 $ 443,781 $ 120,925 $ 540,778
COST OF REVENUES AND OPERATING EXPENSES        
Administrative 2,498 13,986 18,957 9,937
Salary and payroll taxes 29,349 32,300 20,138 15,624
Amortization of intangible assets 755 13,174 16,823 3,521
Goodwill and tradename intangible assets impairment     190,777  
Total cost of revenues and operating expenses 133,395 442,657 385,929 492,257
(Loss) income from operations (14,943) 1,124 (265,004) 48,521
OTHER (EXPENSE) INCOME, NET        
Interest expense and warrant issuance costs (6,316) (13,522) (16,089) (34,099)
Loss on extinguishment of debt (3,413)      
Interest income   43 30 238
Change in fair value of warrant liabilities   (19,700) (6,100)  
Other income       171
Total other expense, net (9,729) (33,179) (22,159) (33,690)
(Loss) income before income tax expense (benefit) (24,672) (32,055) (287,163) 14,831
INCOME TAX EXPENSE (BENEFIT) 109 (120) 814 1,088
NET (LOSS) INCOME (24,781) (31,935) (287,977) 13,743
Net income attributable to noncontrolling interest 678 3,334   3,857
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS AND PARENT, RESPECTIVELY (25,459) $ (35,269) $ (287,977) 9,886
NET LOSS PER VOTING AND NON-VOTING SHARE        
Basic   $ (0.58) $ (3.87)  
Diluted   $ (0.58) $ (3.87)  
WEIGHTED-AVERAGE SHARES OUTSTANDING        
Basic   61,118,000 74,359,000  
Diluted [1]   61,118,000 74,359,000  
Service [Member]        
REVENUES        
REVENUES 91,280 $ 339,793 $ 93,682 410,927
COST OF REVENUES AND OPERATING EXPENSES        
Cost of Revenue 76,836 292,844 107,258 352,382
Product [Member]        
REVENUES        
REVENUES 27,172 103,988 27,243 129,851
COST OF REVENUES AND OPERATING EXPENSES        
Cost of Revenue $ 23,957 $ 90,353 $ 31,976 $ 110,793
[1] Potential common shares under the treasury stock method were antidilutive because the Company reported a net loss in this period. Consequently, the Company did not have any adjustments in this period between basic and diluted loss per share related to stock options, warrants, deferred shares and restricted stock.